New U.S. patent related to Oasmia Pharmaceutical’s nanotechnology platform XR17 Life Science Investing
Denali Therapeutics Announces Positive Clinical Results With Its Lead RIPK1 Inhibitor Molecule Pharmaceutical Investing
PreveCeutical Converts Acidic Phytocannabinoids to Neutral Form and Doubles Contents of Fingerprinted Cannabis Extract Library Cannabis Investing News
Tenax Therapeutics Activates First Clinical Research Site for Phase 2 Pulmonary Hypertension Clinical Trial Life Science Investing
Corcept Therapeutics Announces First Patient Dosed in Phase 3 Trial of Relacorilant Life Science Investing
TRACON Pharmaceuticals Presents Data from Phase 2 Trial of TRC102 and Temodar Pharmaceutical Investing
Atara Biotherapeutics Announces Publication of Phase 1 Study Demonstrating Clinical Improvement Pharmaceutical Investing
PreveCeutical Confirms Encouraging Results from Sol-gel Applicator Trials for Achieving Direct Nose-to-Brain Delivery in an Adult Human Nasal Cast Cannabis Investing News
